Table 1

Clinical characteristic of responders to MTX treatment compared with non-responders

RespondersNon-respondersp Value
Age (y)12.7 (5.9)9.4 (4.1)NS
F:M ratio2.3:11:2.5p<0.001
Disease duration (y)4.7 (4.5)3.4 (2.5)NS
Polyarticular type (%)8 (80)5 (70)NS
Total corticosteroid dose at entry (mg/day)1 (1.7)9.3 (1.2)p<0.001
Number of active joints at entry12.5 (9)12.4 (10.1)NS
Duration of morning stiffness (min)15.5 (20.1)34.3 (20.7)p=0.04
  • Data shown as mean (SD).